Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 15.81% | 20.29% | 20.47% | 22.38% | 17.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.81% | 20.29% | 20.47% | 22.38% | 17.53% |
| Cost of Revenue | 15.65% | 19.79% | 19.82% | 22.49% | 17.95% |
| Gross Profit | 16.19% | 21.46% | 21.96% | 22.12% | 16.59% |
| SG&A Expenses | 17.13% | 21.24% | 20.45% | 21.55% | 11.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -114.67% | -138.23% | -105.97% | -124.15% | 131.80% |
| Total Operating Expenses | 15.80% | 19.57% | 19.67% | 22.13% | 16.28% |
| Operating Income | 16.17% | 36.02% | 38.06% | 27.49% | 48.41% |
| Income Before Tax | 18.40% | 40.79% | 42.41% | -8.43% | 19.42% |
| Income Tax Expenses | 47.67% | -8.28% | -20.84% | -56.07% | -37.71% |
| Earnings from Continuing Operations | 2.01% | 118.01% | 154.30% | 120.40% | 145.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.01% | 118.01% | 154.30% | 120.40% | 145.63% |
| EBIT | 16.17% | 36.02% | 38.06% | 27.49% | 48.41% |
| EBITDA | 8.56% | 18.39% | 20.61% | 42.22% | 41.52% |
| EPS Basic | 1.85% | 116.87% | 153.59% | 121.43% | 147.33% |
| Normalized Basic EPS | 19.62% | 42.48% | 42.48% | -8.59% | 19.25% |
| EPS Diluted | 1.85% | 116.87% | 153.59% | 121.43% | 147.33% |
| Normalized Diluted EPS | 19.62% | 42.48% | 42.48% | -8.59% | 19.25% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
